September 20, 2023
News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. Measures biologic drug products at extremely low sample volumes to determine five critical parameters within one workflow, increasing efficiency, and also improves [...]
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company
September 20, 2023
OREM, Utah -- Reflect Scientific, Inc. (Symbol: RSCF), a pioneering manufacturer in ultra-low temperature storage solutions, is thrilled to announce its most significant single order ever, valued at over $500,000. This landmark deal involves the provision of our state-of-the-art storage freezers to a premier BioPharma company with a market valuation of $40 billion. The contract [...]
September 20, 2023
The GlutenTox® ELISA Rapid G12 test kit offers a systematic method for evaluating gluten content from wheat, barley and rye in food samples. Its precision and reliability have earned it the AOAC RI Performance Tested MethodsSM certification. The kit aligned with AOAC's exacting standards, confirming its capability to accurately detect and quantify wheat gluten in a variety of [...]
September 20, 2023
Manufacture of quality-critical materials for the fast-growing and increasingly relevant market segment of cell and gene therapies Groundbreaking event in the Haid-Süd industrial park with around 150 guests Total investment of around 140 million euros Number of jobs can be more than doubled Freiburg, Germany -- The life science group Sartorius is building a new [...]
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString’s CosMx Products in Europe
September 20, 2023
Second Injunction Issued Against CosMx PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") issued a preliminary injunction against NanoString Technologies, Inc. (Nasdaq: NSTG) for infringing European Patent 4 108 782 B1 ("the EP 782 patent," docket No 459746/2023). The preliminary injunction, issued [...]
September 19, 2023
Deepcell Expands Commercial Capabilities Hiring Mark Aitkenhead, Ph.D., as Chief Commercial Officer MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today announced the appointment of Mark Aitkenhead, Ph.D., to the newly created position of Chief Commercial Officer. “We are delighted to welcome Dr. Aitkenhead to our [...]
Dual-cap sample collection tube for genetic testing workflows
September 19, 2023
Azenta Life Sciences has launched Cap2TM - a new 0.2ml PCR microcentrifuge tube featuring a novel dual-cap design with both hinged lid and screw cap to preserve the integrity of samples used in genetic testing workflows. Acting as both a collection and processing tube, sample transfer can be minimized making for greater efficiency and less wastage. Designed to ensure [...]
ChromaTan™ Appoints Dr. Rajiv Datar as New CEO
September 19, 2023
An innovative biotools company puts an experienced bioentrepreneur at the helm LOWER GWYNEDD, Pa. -- ChromaTanTM announced today that Dr. Rajiv Datar has been appointed the new President & CEO of the company. A bioentrepreneur with over 25 years C-level experience in bioprocessing and drug development, Dr. Datar succeeds Oleg Shinkazh, the Founder of ChromaTan, who [...]
NanoString Comments on Unified Patent Court Order
September 19, 2023
NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in Europe SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified [...]
September 19, 2023
Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to [...]
